scieee Science in your language
[en] (orig)

HMGB1 and Extracellular Histones Significantly Contribute to Systemic Inflammation and Multiple Organ Failure in Acute Liver Failure

Read accessible full text

HMGB1 and Extracellular Histones Significantly Contribute to Systemic Inflammation and Multiple Organ Failure in Acute Liver Failure

Author: Yang, Runkuan,Zou, Xiaoping,Tenhunen, Jyrki,Tonnessen, Tor Inge
Year: 2017
Source: https://trepo.tuni.fi/bitstream/10024/101641/1/hmgb1_and%20_extracellular_histones_2017.pdf
Re iew A icle
HMGB1 and Ex acellula His ones Signi ican ly Con ibu e o
Sys emic In lamma ion and Mul iple O gan Failu e in Acu e
Li e Failu e
Runkuan Yang,
1,2,3
Xiaoping Zou,
4
Jy ki Tenhunen,
1,5
and To Inge Tønnessen
3,6
1
Depa men o In ensi e Ca e Medicine, Tampe e Uni e si y Hospi al, Uni e si y o Tampe e, 10 Bio Ka u, 33014 Tampe e, Finland
2
Depa men o C i ical Ca e Medicine, Uni e si y o Pi sbu gh Medical School, 3550 Te ace S ee , Pi sbu gh, PA 15261, USA
3
Depa men o Eme gencies and C i ical Ca e, Oslo Uni e si y Hospi al, P.O. Box 4950 Nydalen, 0424 Oslo, No way
4
Depa men o Gas oen e ology, D um Towe Hospi al, Nanjing Uni e si y Medical School, 321 Zhongshan S ee ,
Nanjing 210008, China
5
Depa men o Su gical Science, Anes hesiology and In ensi e Ca e Medicine, Uppsala Uni e si y, 751 85 Uppsala, Sweden
6
Ins i u e o Clinical Medicine, Uni e si y o Oslo, Blinde n, 0316 Oslo, No way
Co espondence should be add essed o Runkuan Yang; [email p o ec ed]
Recei ed 25 No embe 2016; Re ised 27 Feb ua y 2017; Accep ed 8 May 2017; Published 13 June 2017
Academic Edi o : Jose C ispin
Copy igh © 2017 Runkuan Yang e al. This is an open access a icle dis ibu ed unde he C ea i e Commons A ibu ion License,
which pe mi s un es ic ed use, dis ibu ion, and ep oduc ion in any medium, p o ided he o iginal wo k is p ope ly ci ed.
Acu e li e ailu e (ALF) is he culmina ion o se e e li e cell inju y om a a ie y o causes. ALF occu s when he ex en o
hepa ocy e dea h exceeds he hepa ic egene a i e capaci y. ALF has a high mo ali y ha is associa ed wi h mul iple o gan
ailu e (MOF) and sepsis; howe e , he unde lying mechanisms a e s ill no clea . Eme ging e idence shows ha ALF pa ien s/
animals ha e high concen a ions o ci cula ing HMGB1, which can con ibu e o mul iple o gan inju ies and media e gu
bac e ial ansloca ion (BT). BT igge s/induces sys emic inflamma o y esponses synd ome (SIRS), which can lead o MOF in
ALF. Blockade o HMGB1 significan ly dec eases BT and imp o es hepa ocy e egene a ion in expe imen al acu e a al li e
inju y. The e o e, HMGB1 seems o be an impo an ac o ha links BT and sys emic inflamma ion in ALF. ALF pa ien s/
animals also ha e high le els o ci cula ing his ones, which migh be he majo media o s o sys emic inflamma ion in pa ien s
wi h ALF. Ex acellula his ones kill endo helial cells and elici immunos imula o y effec o induce mul iple o gan inju ies.
Neu aliza ion o his ones can a enua e acu e li e , lung, and b ain inju ies. In conclusion, HMGB1 and his ones play a
significan ole in inducing sys emic inflamma ion and MOF in ALF.
1. Backg ound
Acu e li e ailu e is defined as a clinical synd ome cha -
ac e ized by li e inju y wi h e idence o coagulopa hy
and any deg ee o al e ed men al s a us in a pa ien wi h-
ou p eexis ing li e disease and du a ion o illness less
han 26 weeks [1–3]. The e iology a ies wi h geog aphy.
Hepa o ophic i uses a e he mos common cause o ALF
in de eloping coun ies [4, 5]; d ugs a e he mos common
cause o ALF in he indus ialized na ions [4, 6]. The mo -
ali y o ALF is as high as 40–50%, and he cause o dea h
in ALF includes b ain he nia ion due o aised in ac anial
p essu e (35%) and sepsis wi h mul iple o gan ailu e [3].
Li e ansplan a ion is he only he apeu ic in e en ion
wi h p o en su i al benefi in pa ien s wi h i e e sible
ALF [2]. ALF pa ien s a e p one o in ec ion due o he
immunologic de ec and he high-dependency ca e hey
equi e [7]. Be ween 39% and 57% o ALF pa ien s expe-
ience bac e ial in ec ion [8]. ALF has a high a e o
in ec ion wi h g am-nega i e en e ic bac e ia in animal
model [9]. G am-nega i e and g am-posi i e bac e ia can
elici sepsis [7]. In ec ions and/o he esul ing SIRS a e
impo an con ibu ing ac o s ha wo sen hepa ic ence-
phalopa hy (HE) [8]. ALF is associa ed wi h MOF and a
high incidence o sepsis (35.7%), which con ibu es o
23.1% o he mo ali y [7]; howe e , he unde lying
Hindawi
Media o s o Inflamma ion
Volume 2017, A icle ID 5928078, 6 pages
h ps://doi.o g/10.1155/2017/5928078
mechanism is s ill no clea . Ea ly inflamma o y media o s
(such as TNF-α, IL-6, and IL-1β) a e ce ainly in ol ed in
he pa hogenesis o ALF [10]; howe e , hese ea ly cy o-
kines ha e limi ed clinical significance due o he na ow
he apeu ic window. In con as , HMGB1 is a la e media-
o o le hal sys emic inflamma ion [11], and HMGB1 has
a p olonged he apeu ic window as compa ed o hose
ea ly inflamma o y cy okines; ci cula ing TNF-αand IL-6
a e ele a ed o 5 days a e he onse o sepsis, and se um
HMGB1 le els a e inc eased om day 7 un il a leas day
28 [12]. Eme ging e idences indica e ha HMGB1 is an
impo an ac o ha links gu BT and sepsis, and ex a-
cellula his ones a e also impo an ac o s ha signifi-
can ly con ibu e o MOF in ALF. In his manusc ip , we
e iew he cu en unde s anding o HMGB1 and his ones
in ALF.
2. The Role o HMGB1 in ALF
2.1. HMGB1 is a Typical Ala min. Endogenous dange -
associa ed molecula pa e ns (DAMPs) a e also known as
ala mins, which signal cellula damage and ac i a e he
inna e immune sys em [13]. Ala mins sha e he ollowing
ea u es: (a) apid elease om cells in esponse o in ec ion
o issue damage, (b) chemoa ac ion and ac i a ion o
an igen-p esen ing cells, and (c) ac i a ion o inna e and
adap i e immuni y [14]. HMGB1 is a ypical ala min [14].
2.2. Passi e Release. HMGB1 can be passi ely eleased by
nec o ic/damaged cells o ac i ely sec e ed by immuno-
compe en cells [15]. Unde nec o ic condi ion, con en s
o he cy osol a e dispe sed in o he ex acellula space
due o cellula dis ess o damage [16]. In nec o ic cells,
HMGB1 dissocia es om ch oma in and is eleased om
cells o igge inflamma ion. Howe e , HMGB1 emains
bound o ch oma in and ails o p omo e inflamma ion
in cells unde going apop o ic o p og ammed cell dea h,
in which cy osolic con en s a e seques e ed and no “seen”
by inna e immune cells [16].
2.3. Ac i e Sec e ion. In esponse o p oinflamma o y s imuli
such as LPS, HMGB1 can be ac i ely sec e ed by immuno-
compe en cells. This ac i e sec e ion occu s h ough a
wo-s ep p ocess. Fi s , HMGB1 is ansloca ed ou o
he nucleus o he cy oplasm a e JAK/STAT1- egula ed
hype -ace yla ion o lysine esidues loca ed in he A and
B box domains [17]. Once in he cy oplasm, HMGB1 is
ac i ely sec e ed [17]. The ac i e sec e ion o HMGB1
ollows a nonclassical, esicle-media ed pa hway [18].
2.4. Redox S a e and Ex acellula Func ions. HMGB1 con-
ains h ee conse ed edox-sensi i e cys eines (C23, C45,
and C106), and pos ansla ional modifica ion (oxida ion)
o hese cys eines de e mines he bioac i i y o ex acellula
HMGB1 [19]. The cy okine-s imula ing ac i i y o HMGB1
equi es C23 and C45 o be in a disulfide linkage, while
C106 emains in a educed s a e. This disulfide HMGB1
can bind and signal ia TLR4/MD-2 complex o induce
cy okine elease in mac ophage [19]. Mo eo e , binding o
HMGB1 o TLR4 depends on educed Cys106 [20]. I all
h ee cys eines a e in educed o m, his all- hiol HMGB1
has chemo ac ic ac i i y. This o m is p esen unde basal
condi ions. Unde inflamma o y condi ions, his all- hiol
HMGB1 is eleased and o ms a he e ocomplex wi h he
chemokine CXCL12 o in e ac wi h he chemokine ecep o
CXCR4 o p omo e cell mig a ion, bu no inflamma o y
cy okine sec e ion. The hi d o m o HMGB1 occu s unde
a s a e o comple e oxida ion whe ein each cys eine is ully
oxidized o a sul onyl o m and is no associa ed wi h any
biological unc ion [19]. Hype ace yla ion o HMGB1 shi s
i s equilib ium om a p edominan nuclea loca ion owa d
a cy osolic and subsequen ex acellula p esence. Hence,
pos ansla ional modifica ions o HMGB1 de e mine i s
ole in inflamma ion and immuni y [19].
2.5. ALF Releases HMGB1 as a Signal o Inflamma ion. ALF
occu s when he ex en o hepa ocy e dea h exceeds he
hepa ic egene a i e capaci y [21], and he mode o he cell
dea h ypically ollows one o he wo pa e ns: nec osis o
apop osis [21]. In a clinical ial, HMGB1 ep esen s he
ci cula ing indica o o nec osis du ing ace aminophen hep-
a o oxici y; ull-leng h and caspase-clea ed ke a in-18 a e
ci cula ing ma ke s o nec osis and apop osis; hype -
ace yla ed HMGB1 is a se um indica o o py op osis and
immune cell ac i a ion [22, 23]. Ele a ions in plasma
HMGB1 and ke a in-18 can se e as mechanis ic bioma ke s
o p o ide ea ly and sensi i e de ec ion o ace aminophen-
induced acu e li e inju y a fi s p esen a ion o a hospi al
[22]. Inc eased o al and ace yla ed HMGB1 and ull-
leng h ke a in-18 a e associa ed wi h wo se p ognosis
du ing clinical ace aminophen hepa o oxici y [23]. HMGB1
can be eleased eadily om nec o ic o damaged cells o
se e as a signal o inflamma ion [16, 24]. HMGB1 plays
an impo an ole in modula ing inflamma o y cascade in
ac i a ed mac ophages: HMGB1 s imula es mac ophages
o elease TNF-αand IL-6 [20, 25]. HMGB1 is a po en
media o o sys emic inflamma ion in sepsis [26].
2.6. HMGB1 Con ibu es o Mul iple O gan Inju ies. HMGB1
con ibu es o li e inju y in expe imen al ischemia-
epe usion [27]. Exogenous HMGB1 injec ion can induce
e iden li e inju y in mice [28]. HMGB1 impai s hepa ocy e
egene a ion and blockade o HMGB1 imp o es hepa ocy e
egene a ion in mice challenged wi h ace aminophen o e -
dose [29]. A pa ly humanized an i-HMGB1 monoclonal
an ibody a enua es ace aminophen hepa o oxici y and
pos inju y inflamma ion in mice [30]. HMGB1 is eleased
in o he se um a ea ly s age o D-galac osamine/LPS-
induced ALF, and HMGB1 ac s syne gis ically wi h TNF-α
o p omo e he inflamma o y li e inju y; his de imen al
effec can be e e sed by monoclonal an ibodies agains
HMGB1 and TNF-α[31]. Inhibi ion o sphingosine kinase-
1 amelio a es expe imen al ALF by educing high-mobili y
g oup box 1 cy oplasmic ansloca ion in li e cells [32].
HMGB1 con ibu es o enal ischemia- epe usion inju y
[33], sepsis-induced kidney inju y [34], and se e e acu e
panc ea i is- ela ed kidney inju y [35]. HMGB1 also signifi-
can ly con ibu es o hemo hagic shock- ela ed acu e lung
2 Media o s o Inflamma ion
inju y (ALI) [36], hype oxia-induced ALI [37], and se e e
acu e panc ea i is- ela ed ALI [38].
2.7. HMGB1 Con ibu es o Gu Mucosal Inju y and Media es
Gu BT in ALF. Gu mucosal inju y and in es inal BT in ALF
is pa icula ly impo an because he in es ine is he bigges
ese oi o bac e ia in he body and leakage o bac e ia o
mic obial p oduc s, no ably LPS, om he lumen o he gu
in o he sys emic ci cula ion, leads o ini ia ion o amplifica-
ion o a sys emic inflamma o y esponse synd ome and
mul iple o gan dys unc ion synd ome (MODS). The e o e,
he leaky gu is hough o be he “mo o ” ha d i es he
de elopmen o MODS [39].
The se um HMGB1 concen a ions a e significan ly
inc eased in mice challenged wi h ace aminophen o e dose
[29, 40]. ALF pa ien s also ha e high concen a ions o ci cu-
la ing HMGB1, and he ci cula ing HMGB1 le els a e associ-
a ed wi h disease se e i y [41, 42]. The ci cula ing HMGB1
con ibu es o gu mucosal hype pe meabili y and induces
e iden BT in expe imen al hemo hagic shock and epe u-
sion [43], and exogenous HMGB1 injec ion can induce gu
hype pe meabili y and BT in mice [28]. Excep om he
ci cula ing HMGB1, bile HMGB1 migh also significan ly
con ibu e o in es inal mucosa inju y and induce e iden
BT in ALF, because hepa i is E i us- ela ed ALF is associ-
a ed wi h significan ly inc eased ci cula ing LPS [44], and
LPS injec ion educes 40% o bile flow in a s [45]; adequa e
bile is equi ed o main ain gu epi helial igh junc ion and
in es inal bac e ial homeos asis [46]; dec eased gu luminal
bile olume no only impai s in es inal igh junc ion bu
also changes in es inal bac e ial homeos asis o acili a e
BT [46, 47]. In addi ion, LPS injec ion ( o no mal animals)
ma kedly inc eases bile TNF-αand HMGB1 le els, which
can induce gu mucosal hype pe meabili y and e iden BT
in mice [45], and his de imen al effec can be e e sed by
neu aliza ion o he bile HMGB1 [45].
Expe imen al hepa o oxici y is associa ed wi h high inci-
dence o gu de i ed g am-nega i e bac e ial in ec ion [9, 40].
Ace aminophen o e dose can induce e iden gu BT and
se e e in es inal mucosal inju y in mice [40], and gu bac e ia
can adhe e o he inju ed mucosa, which is necessa y bu no
sufficien o induce gu BT [40], because blockade o HMGB1
educes 85% o gu BT, bu i does no dec ease gu mucosal
pe meabili y in expe imen al ace aminophen o e dose [40].
This indica es ha BT is media ed (a leas pa ly) by
HMGB1 and BT is likely an ac i e “ anscellula ”p ocedu e
in which HMGB1 is also needed.
2.8. BT Induces/T igge s Sys emic Inflamma ion, Which Leads
o MOF in ALF. Gu BT (o gu -de i ed LPS) induces/ igge s
sys emic inflamma ion in c i ical illness [48, 49]. SIRS can
lead o MOF in ALF [7]. Sepsis is a ypical example o
SIRS igge ed by in ec ion [50]. The e o e, HMGB1 seems
o be an impo an ac o ha links BT and SIRS in ALF.
3. The Role o Ex acellula His ones in ALF
3.1. ALF Pa ien s/Animals Ha e High Concen a ions o
Ci cula ing His ones. ALF has a la ge numbe o hepa ocy e
dea h [21]. The nec o ic issue/ he dying hepa ocy es
elease HMGB1 and his ones [50], which can con ibu e
o he high concen a ions o ci cula ing his ones in ani-
mals challenged wi h concana alin A and ace aminophen
o e dose o induce wo diffe en acu e a al li e inju y
models [50]. Ci cula ing his ones a e significan ly inc eased
in ALF pa ien s and in pa ien s wi h HBV- ela ed acu e-on-
ch onic li e ailu e, and he le els o ci cula ing his ones
a e co ela ed wi h disease se e i y and mo ali y [51, 52].
ALF pa ien s also ha e ele a ed plasma his one-associa ed
DNA le els [53]. DAMPs ac i a e inna e immune cells in
he li e and he ci cula ion, subsequen ly leading o issue
inflamma ion and SIRS [53, 54].
3.2. Ex acellula His ones Con ibu e o Mul iple O gan
Inju ies in ALF. His ones a e impo an s uc u al elemen s
o nuclea ch oma in and egula e gene ansc ip ion [54];
howe e , ex acellula his ones a e cell oxic o hos cells
[50, 54] and elici immunos imula o y effec ha can induce
mul iple o gan inju ies [50, 53–55]. Ci cula ing his ones
exace ba e inflamma ion in mice wi h ALF [56]. The se a
(con aining high le els o his ones) om ALF pa ien s can
induce L02 cell (hepa ocy e) dea h and s imula e U937 cells
(monocy es) o elease inflamma o y cy okines; hese de i-
men al effec s can be abolished by non-an icoagulan hepa in
ha can bind his ones, sugges ing ha ci cula ing his ones
migh be he majo media o s o sys emic inflamma ion
and cellula inju y in pa ien s wi h ALF [51]. The ci cula ing
angiopoie in-2 le els, a ma ke o issue endo helial dys unc-
ion and leakage, a e ma kedly inc eased in ALF pa ien s
[53], and his migh be due o he oxici y o ex acellula his-
ones in ALF pa ien s. Ex acellula his ones con ibu e o
acu e a al li e inju y ia TLR 2 and TLR4 ecep o s, and
neu aliza ion o his ones can amelio a e a al li e inju y in
mice [50]. The le els o ci cula ing his ones a e significan ly
highe a e li e ischemia/ epe usion, he endogenous
his ones unc ion as ala mins in s e ile inflamma o y li e
inju y h ough oll-like ecep o 9, and neu aliza ion o
his one significan ly p o ec s agains inju y [57]. Ex acellu-
la his ones can induce mic o ascula endo helial inju y,
and he TLR2/4-media ed inflamma ion leads o acu e ubu-
la nec osis in expe imen al acu e kidney inju y [58, 59].
Ex acellula his ones can inju e endo helial cells o cause
mic o ascula h ombosis and hemo hage in expe imen al
acu e lung inju y [60]. His ones also con ibu e o expe i-
men al acu e b ain inju y, and neu aliza ion o his ones
can educe he in a c size [61]. His one H4 and inc eased
ci cula ing neu ophil ex acellula aps (NETs) can ac i a e
pla ele s; his may cause mic o ascula h ombosis in sepsis
[50, 55, 59, 62]. HMGB1 may induce he same biological
esponse [63]. Ex acellula his ones kill endo helial cells
and a e one o he majo media o s o dea h in sepsis [55].
4. Conclusions
HMGB1 and ex acellula his ones play a significan ole in
inducing sys emic inflamma ion and MOF in ALF; neu ali-
za ion o HMGB1 and his ones may p esen a no el he apy
o ea ALF.
3Media o s o Inflamma ion
A g aphical abs ac is p o ided as he Supplemen a y
ma e ial a ailable online a h ps://doi.o g/10.1155/2017/
5928078.
Abb e ia ions
ALF: Acu e li e ailu e
MOF: Mul iple o gan ailu e
SIRS: Sys emic inflamma o y esponse synd ome
BT: Bac e ial ansloca ion
HMGB1: High mobili y g oup box 1
NETs: Neu ophil ex acellula aps
DAMP: Damage-associa ed molecula pa e n
TLR: Toll-like ecep o
APAP: Ace aminophen
MODS: Mul iple o gan dys unc ion synd ome
MD-2: Myeloid diffe en ia ion ac o 2
LPS: Lipopolysaccha ide
D-GalN: D-galac osamine
Sphk1: Sphingosine kinase 1.
Con lic s o In e es
The au ho s decla e ha hey ha e no compe ing in e es s.
Au ho s’Con ibu ions
Runkuan Yang designed and d a ed he manusc ip .
Xiaoping Zou ca ied ou he li e a u e sea ch and d a ed
he manusc ip . To Inge Tønnessen d a ed and e ised
he manusc ip .
Acknowledgmen s
This in es iga ion was pa ly suppo ed by Sig id Juselius
Funding in Finland and Sou h-Eas e n No way Regional
Heal h Au ho i y, G an no. 2013121.
Re e ences
[1] J. Polson and W. M. Lee, “Ame ican associa ion o he s udy
o li e disease. AASLD posi ion pape : he managemen o
acu e li e ailu e,”Hepa ology, ol. 41, pp. 1179–1197, 2005.
[2] W. Be nal and J. Wendon, “Acu e li e ailu e,”The New
England Jou nal o Medicine, ol. 369, pp. 2525–2534, 2013.
[3] W. M. Lee, “Acu e li e ailu e,”Semina s in Respi a o y and
C i ical Ca e Medicine, ol. 33, pp. 36–45, 2012.
[4] W. Be nal, G. Auzinge , A. Dhawan, and J. Wendon, “Acu e
li e ailu e,”Lance , ol. 376, pp. 190–201, 2010.
[5] A. M. La son, “Diagnosis and managemen o acu e li e
ailu e,”Cu en Opinion in Gas oen e ology, ol. 26,
pp. 214–221, 2010.
[6] A. Reuben, D. G. Koch, W. M. Lee, and Acu e li e ailu e
s udy G oup, “D ug-induced acu e li e ailu e: esul s o a
U.S. mul icen e , p ospec i e s udy,”Hepa ology, ol. 52,
pp. 2065–2076, 2010.
[7] N. Rolando, J. Wade, M. Da alos, J. Wendon, J. Philpo -
Howa d, and R. Williams, “The sys emic inflamma o y
esponse synd ome in acu e li e ailu e,”Hepa ology,
ol. 32, pp. 734–739, 2000.
[8] J. Vaque o, J. Polson, C. Chung e al., “In ec ion and he
p og ession o hepa ic encephalopa hy in acu e li e ailu e,”
Gas oen e ology, ol. 125, pp. 755–764, 2003.
[9] F. B. Kas a i, L. Q. Wang, X. D. Wang, G. Molin, S. Bengma k,
and B. Jeppsson, “Bac e ial ansloca ion in acu e li e
inju y induced by D-galac osamine,”Hepa ology, ol. 23,
pp. 97–103, 1996.
[10] R. Yang, X. Zou, M. L. Koskinen, and J. Tenhunen, “E hyl
py u a e educes li e inju y a ea ly phase bu impai s
egene a ion a la e phase in ace aminophen o e dose,”
C i ical Ca e, ol. 16, p. R9, 2012.
[11] Y. Zhang, W. Li, S. Zhu e al., “Tanshinone IIA sodium
sul ona e acili a es endocy ic HMGB1 up ake,”Biochemical
Pha macology, ol. 84, pp. 1492–1500, 2012.
[12] S. I. Valdes-Fe e , J. Papoin, M. E. Dancho e al., “HMGB1
media es anemia o inflamma ion in mu ine sepsis su i o s,”
Molecula Medicine, ol. 21, no. 1, pp. 951–958, 2015.
[13] M. E. Bianchi, “DAMPs, PAMPs and ala mins: all we need o
know abou dange ,”Jou nal o Leukocy e Biology, ol. 81,
pp. 1–5, 2007.
[14] D. S. Pise sky, H. E landsson-Ha is, and U. Ande sson,
“High-mobili y g oup box p o ein1 (HMGB1): an ala min
media ing he pa hogenesis o heuma ic disease,”A h i is
Resea ch & The apy, ol. 10, p. 209, 2008.
[15] H. Yang, H. Wang, Y. A. Le ine e al., “Iden ifica ion o CD163
as an an i-inflamma o y ecep o o HMGB1-hap oglobin
complexes,”JCI Insigh , ol. 1, 2016.
[16] P. Scaffidi, T. Mis eli, and M. E. Bianchi, “Release o ch oma in
p o ein HMGB1 by nec o ic cells igge s inflamma ion,”
Na u e, ol. 418, pp. 191–195, 2002.
[17] B. Lu, D. J. An oine, K. Kwan e al., “JAK/STAT1signal-
ing p omo es HMGB1 hype ace yla ion and nuclea
ansloca ion,”P oceedings o he Na ional Academy o
Sciences o he Uni ed S a es o Ame ica, ol. 111,
pp. 3068–3073, 2014.
[18] S. Ga della, C. And ei, D. Fe e a e al., “The nuclea p o-
ein HMGB1 is sec e ed by monocy es ia a non-classical,
esicle-media ed sec e o y pa hway,”EMBO Repo s, ol. 3,
pp. 995–1001, 2002.
[19] H. Yang, D. J. An oine, U. Ande sson, and K. J. T acey, “The
many aces o HMGB1: molecula s uc u e- unc ional ac i i y
in inflamma ion, apop osis and chemo axis,”Jou nal o
Leukocy e Biology, ol. 93, pp. 865–873, 2013.
[20] H. Yang, H. S. H egg idsdo i , K. Palmblad e al., “A c i ical
cys eine is equi ed o HMGB1 binding o oll-like ecep o
4 and ac i a ion o mac ophage cy okine elease,”PNAS,
ol. 26, pp. 11942–11947, 2010.
[21] A. Ru he o d and R. T. Chung, “Acu e li e ailu e:
mechanisms o hepa ocy e inju y and egene a ion,”Semina s
in Li e Disease, ol. 28, pp. 167–174, 2008.
[22] D. J. An oine, J. W. Dea , P. S. Lewis e al., “Mechanis ic
bioma ke s p o ide ea ly and sensi i e de ec ion o
ace aminophen-induced acu e li e inju y a fi s p esen a ion
o hospi al,”Hepa ology, ol. 58, pp. 777–787, 2013.
[23] D. J. An oine, R. E. Jenkins, J. W. Dea e al., “Molecula
o ms o HMGB1 and ke a in-18 as mechanis ic bioma ke s
o mode o cell dea h and p ognosis du ing clinical ace -
aminophen hepa o oxici y,”Jou nal o Hepa ology, ol. 56,
pp. 1070–1079, 2012.
[24] M. E. Bianchi and A. A. Man edi, “High mobili y g oup B1
(HMGB1) p o ein a he c oss oads be ween inna e and
4 Media o s o Inflamma ion
adap i e immuni y,”Immunological Re iews, ol. 220,
pp. 35–46, 2007.
[25] D. Ge o, P. Szoleczky, K. Modis e al., “Iden ifica ion o pha -
macological modula o s o HMGB1-induced inflamma o y
esponse by cell-based sc eening,”PloS One, ol. 8, a icle
e65994, 2013.
[26] B. Cai, E. A. Dei ch, and L. Ulloa, “No el insigh s o sys emic
inflamma ion in sepsis and hemo hage,”Media o s o
Inflamma ion, ol. 2010, A icle ID 642462, 2010.
[27] H. Huang, S. Tohme, A. B. Al-kha aji e al., “Damage-
associa ed molecula pa e n-ac i a ed neu ophil ex acel-
lula ap exace ba es s e ile inflamma o y li e inju y,”
Hepa ology, ol. 62, pp. 600–614, 2015.
[28] P. L. Sapping on, R. Yang, H. Yang, K. J. T acey, R. L. Delude ,
and M. P. Fink, “HMGB1 B box inc eases he pe meabili y o
Caco-2 en e ocy ic monolaye s and impai s in es inal ba ie
unc ion in mice,”Gas oen e ology, ol. 123, pp. 790–802,
2002.
[29] R. Yang, S. Zhang, A. Co oia, N. Oksala, S. Zhu, and J.
Tenhunen, “High mobili y g oup B1 impai s hepa ocy e
egene a ion in ace aminophen hepa o oxici y,”BMC
Gas oen e ology, ol. 12, p. 45, 2012.
[30] P. Lundback, J. D. Lea, A. Sowinska e al., “A no el high
mobili y g oup box 1 neu alizing chime ic an ibody a enu-
a es d ug-induced li e inju y and pos inju y inflamma ion
in mice,”Hepa ology, ol. 64, pp. 1699–1710, 2016.
[31] W. Wang, L. Sun, Y. Deng, and J. Tang, “Syne gis ic effec s o
an ibodies agains high-mobili y g oup box 1 and umo
nec osis ac o -a on D- (+)-galac osamine hyd ochlo ide/lipo-
polysaccha ide-induced acu e li e ailu e,”The FEBS Jou nal,
ol. 280, pp. 1409–1419, 2013.
[32] Y. C. Lei, L. L. Yang, W. Li, P. Luo, and P. F. Zheng, “Inhibi ion
o sphingosine kinase 1 amelio a es acu e li e ailu e by
educing high-mobili y g oup box 1 cy oplasmic ansloca ion
in li e cells,”Wo ld Jou nal o Gas oen e ology, ol. 21,
pp. 13055–13063, 2015.
[33] A. Lau, S. Wang, W. Liu, A. Haig, Z. Zhang, and A. M.
Je nika , “Glycy hizic acid amelio a es HMGB1-media ed
cell dea h and inflamma ion a e enal ischemia epe u-
sion inju y,”Ame ican Jou nal o Neph ology, ol. 40,
pp. 84–95, 2014.
[34] Y. Hu, M. H. Pai, C. L. Yeh, Y. C. Hou, and S. L. Yeh, “Glu a-
mine adminis a ion amelio a es sepsis-induced kidney inju y
by down egula ing he high-mobili y g oup box p o ein-1-
media ed pa hway in mice,”Ame ican Jou nal o Physiology.
Renal Physiology, ol. 302, pp. F150–F158, 2012.
[35] H. Sawa, T. Ueda, Y. Takeyama e al., “Blockade o high
mobili y g oup box-1 p o ein a enua es expe imen al se e e
acu e panc ea i is,”Wo ld Jou nal o Gas oen e ology,
ol. 12, pp. 7666–7670, 2006.
[36] R. L. Kao, X. Xu, A. Xenocos as e al., “Induc ion o acu e lung
inflamma ion in mice wi h hemo hagic shock and epe u-
sion: ole o HMGB1,”Jou nal o Inflamma ion (London,
England), ol. 11, pp. 30–37, 2014.
[37] M. En eza i, M. Ja dan, D. J. An oine e al., “Inhibi ion o ex a-
cellula HMGB1 a enua es hype oxia-induced inflamma o y
acu e lung inju y,”Redox Biology, ol. 2, pp. 314–322, 2014.
[38] Z. Luan, X. Zhang, X. Yin e al., “Down egula ion o HMGB1
p o ec s agains he de elopmen o acu e lung inju y
a e se e e acu e panc ea i is,”Immunobiology, ol. 218,
pp. 1261–1270, 2013.
[39] M. P. Fink, “Leaky gu hypo hesis: a his o ical pe spec i e,”
C i ical Ca e Medicine, ol. 18, pp. 579-580, 1990.
[40] R. Yang, X. Zou, J. Tenhunen e al., “Neu aliza ion o HMGB1
is associa ed wi h bac e ial ansloca ion du ing ace amino-
phen hepa o oxici y,”BMC Gas oen e ology, ol. 14, p. 66,
2014.
[41] M. Majumda , R. Ra ho, Y. Chawla, and M. P. Singh, “High
le els o ci cula ing HMGB1 as a bioma ke o acu e li e
ailu e in pa ien s wi h hepa i is E,”Li e In e na ional,
ol. 33, pp. 1341–1348, 2013.
[42] G. Oshima, M. Shinoda, M. Tanabe e al., “Inc eased plasma
le els o high mobili y g oup box 1 in pa ien s wi h acu e li e
ailu e,”Eu opean Su gical Resea ch, ol. 48, pp. 154–162,
2012.
[43] R. Yang, T. Ha ada, K. P. Mollen e al., “An i-HMGB1
neu alizing an ibody amelio a es gu ba ie dys unc ion
and imp o es su i al a e hemo hagic shock,”Molecula
Medicine, ol. 12, pp. 105–114, 2006.
[44] F. Wu, M. Wang, and D. Tian, “Se um om pa ien s wi h
hepa i is E i us- ela ed acu e li e ailu e induces human li e
cell apop osis,”Expe imen al and The apeu ic Medicine, ol. 7,
pp. 300–304, 2014.
[45] R. Yang, K. Miki, N. Oksala e al., “Bile high mobili y g oup
box 1 con ibu es o gu ba ie dys unc ion in expe imen al
endo oxemia,”Ame ican Jou nal o Physiology. Regula o y,
In eg a i e and Compa a i e Physiology, ol. 297, pp. R362–
R369, 2009.
[46] R. Yang, T. Ha ada, J. Li e al., “Bile modula es in es inal
epi helial ba ie unc ion ia ex acellula signal ela ed kinase
½ dependen mechanism,”In ensi e Ca e Medicine, ol. 31,
pp. 709–717, 2005.
[47] Y. Oga a, M. Nishi, H. Nakayama, T. Kuwaha a, Y. Ohnishi,
and S. Tashi o, “Role o bile in in es inal ba ie unc ion and
i s inhibi o y effec on bac e ial ansloca ion in obs uc i e
jaundice in a s,”The Jou nal o Su gical Resea ch, ol. 115,
pp. 18–23, 2003.
[48] M. Fanous, A. J. Phillips, and J. A. Windso , “Mesen e ic
lymph: he b idge o u u e managemen o c i ical illness,”
JOP: Jou nal o he Panc eas, ol. 8, pp. 374–399, 2007.
[49] N. Runkel, “Bac e ial ansloca ion in acu e panc ea i is,”
Diges i e Su ge y, ol. 13, pp. 269–272, 1996.
[50] J. Xu, X. Zhang, M. Mones ie , N. L. Esmon, and C. T. Esmon,
“Ex acellula his ones a e media o s o dea h h ough TLR2
and TLR4 in mouse a al li e inju y,”Jou nal o Immunology,
ol. 187, pp. 2626–2631, 2011.
[51] Z. Wen, Z. Lei, L. Yao e al., “Ci cula ing his ones a e majo
media o s o sys emic inflamma ion and cellula inju y in
pa ien s wi h acu e li e ailu e,”Cell Dea h & Disease, ol. 7,
a icle e2391, 2016.
[52] X. Li, C. Gou, L. Yao e al., “Pa ien s wi h HBV- ela ed acu e-
on-ch onic li e ailu e ha e inc eased concen a ions o
ex acellula his ones agg a a ing cellula damage and sys-
emic inflamma ion,”Jou nal o Vi al Hepa i is, ol. 24,
pp. 59–67, 2017.
[53] F. S. La sen, L. E. Schmid , C. Be nsmeie e al., “High- olume
plasma exchange in pa ien s wi h acu e li e ailu e: an open
andomized con olled ial,”Jou nal o Hepa ology, ol. 64,
pp. 69–78, 2016.
[54] R. Allam, S. V. R. Kuma , M. N. Da isipudi, and H. J. Ande s,
“Ex acellula his ones in issue inju y and inflamma ion,”
Jou nal o Molecula Medicine, ol. 92, pp. 465–472, 2014.
5Media o s o Inflamma ion

[55] J. Xu, X. Zhang, R. Pelayo e al., “Ex acellula his ones a e
majo media o s o dea h in sepsis,”Na u e Medicine,
ol. 15, pp. 1318–1321, 2009.
[56] Z. Wen, Y. Liu, F. Li e al., “Ci cula ing his ones exace ba e
inflamma ion in mice wi h acu e li e ailu e,”Jou nal o
Cellula Biochemis y, ol. 114, pp. 2384–2391, 2013.
[57] H. Huang, J. E anko ich, W. Yan e al., “Endogenous his ones
unc ion as ala mins in s e ile inflamma o y li e inju y
h ough oll-like ecep o 9 in mice,”Hepa ology, ol. 54,
pp. 999–1008, 2011.
[58] R. Allam, C. R. Sche baum, M. N. Da isipu i e al., “His ones
om dying enal cells agg a a e kidney inju y ia TLR2 and
TLR4,”Jou nal o he Ame ican Socie y o Neph ology,
ol. 23, pp. 1375–1388, 2012.
[59] D. L. Rosin and M. D. Okusa, “Dying cells and ex acellula
his ones in AKI: beyond a NET effec ?”Jou nal o he
Ame ican Socie y o Neph ology, ol. 23, pp. 1275–1277,
2012.
[60] M. Bosmann, J. J. G aile , R. Ruemmle e al., “Ex acellula
his ones a e essen ial effec o o C5aR- and C5L2-media ed
issue damage and inflamma ion in acu e lung inju y,”The
FASEB Jou nal, ol. 27, pp. 5010–5021, 2013.
[61] S. F. De Meye , G. L. Suidan, T. A. Fuchs, M. Mones ie ,
and D. D. Wagne , “Ex acellula ch oma in is an impo an
media o o ischemic s oke in mice,”A e ioscle osis, Th om-
bosis, and Vascula Biology, ol. 32, pp. 1884–1891, 2012.
[62] R. Yang, J. Tenhunen, and T. I. Tonnessen, “HMGB1 and
his ones play a significan ole in inducing sys emic in-
flamma ion and mul iple o gan dys unc ions in se e e
acu e panc ea i is,”In e na ional Jou nal o Inflamma ion,
ol. 2017, A icle ID 1817564, 2017.
[63] J. M. Tadie, H. B. Bae, S. Jiang e al., “HMGB1 p omo es
neu ophil ex acellula ap o ma ion h ough in e ac ions
wi h oll-like ecep o 4,”Ame ican Jou nal o Physiology.
Lung Cellula and Molecula Physiology, ol. 304, pp. L342–
L349, 2013.
6 Media o s o Inflamma ion
Submi you manusc ip s a
h ps://www.hindawi.com
S em Cells
In e na ional
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
o
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Beha iou al
Neu ology
Endoc inology
In e na ional Jou nal o
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Disease Ma ke s
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
BioMed
Resea ch In e na ional
Oncology
Jou nal o
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Oxida i e Medicine and
Cellula Longe i y
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
PPAR Resea ch
The Scien i ic
Wo ld Jou nal
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Immunology Resea ch
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Jou nal o
Obesi y
Jou nal o
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Compu a ional and
Ma hema ical Me hods
in Medicine
Oph halmology
Jou nal o
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Diabe es Resea ch
Jou nal o
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Resea ch and T ea men
AIDS
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Gas oen e ology
Resea ch and P ac ice
Hindawi Publishing Co po a ion
h p://www.hindawi.com Volume 2014
Pa kinson’s
Disease
E idence-Based
Complemen a y and
Al e na i e Medicine
Volume 2014
Hindawi Publishing Co po a ion
h p://www.hindawi.com